RhumbLine Advisers’s Zomedica Corp. ZOM Stock Holding History

RhumbLine Advisers’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-45,516	Closed	-$6.64K	–	4420
2024 Q2	$6.64K	Sell	45,516 -24,395	-35%	-$3.65K	﹤0.01%	4038
2024 Q1	$10.2K	Hold	69,911	–	–	﹤0.01%	3868
2023 Q4	$14K	Hold	69,911	–	–	﹤0.01%	3818
2023 Q3	$11.7K	Hold	69,911	–	–	﹤0.01%	3853
2023 Q2	$14K	Hold	69,911	–	–	﹤0.01%	3867
2023 Q1	$15K	Hold	69,911	–	–	﹤0.01%	2942
2022 Q4	$11K	Hold	69,911	–	–	﹤0.01%	2989
2022 Q3	$15K	Hold	69,911	–	–	﹤0.01%	3070
2022 Q2	$15K	Buy	+69,911	New	+$17.8K	﹤0.01%	3082
2019 Q2	–	Sell	-45,375	Closed	-$16K	–	3039
2019 Q1	$16K	Sell	45,375 -1,035	-2%	-$913	﹤0.01%	2936
2018 Q4	$57K	Buy	46,410 +16,750	+56%	+$26.6K	﹤0.01%	2934
2018 Q3	$55K	Sell	29,660 -2,025	-6%	-$4.33K	﹤0.01%	2906
2018 Q2	$71K	Buy	+31,685	New	+$63.6K	﹤0.01%	2895

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RhumbLine Advisers's ZOM Position: Q3 2024 in Review

RhumbLine Advisers sold out of Zomedica Corp. (ZOM) in Q3 2024, closing a stake of 45,516 shares — an estimated $6.64K sold.

RhumbLine Advisers first reported a position in ZOM in Q2 2018 and held it in 13 quarters. The position peaked at $71K in Q2 2018. 84 funds tracked by Wall St. Rank hold ZOM as of Q3 2024.

RhumbLine Advisers reported no remaining Zomedica Corp. position as of Q3 2024 after selling out during the quarter.
RhumbLine Advisers sold 45,516 Zomedica Corp. shares in Q3 2024, an estimated $6.64K.
RhumbLine Advisers first reported a position in Zomedica Corp. in Q2 2018 and held it in 13 quarters.
RhumbLine Advisers's Zomedica Corp. position peaked at $71K in Q2 2018.
84 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.